CN108285908B - 一种固定化双酶催化合成(s)-1-(2,6-二氯-3-氟-苯基)乙醇的方法 - Google Patents
一种固定化双酶催化合成(s)-1-(2,6-二氯-3-氟-苯基)乙醇的方法 Download PDFInfo
- Publication number
- CN108285908B CN108285908B CN201711434891.1A CN201711434891A CN108285908B CN 108285908 B CN108285908 B CN 108285908B CN 201711434891 A CN201711434891 A CN 201711434891A CN 108285908 B CN108285908 B CN 108285908B
- Authority
- CN
- China
- Prior art keywords
- dichloro
- fluoro
- phenyl
- ethanol
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 42
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 27
- JAOYKRSASYNDGH-BYPYZUCNSA-N (1s)-1-(2,6-dichloro-3-fluorophenyl)ethanol Chemical compound C[C@H](O)C1=C(Cl)C=CC(F)=C1Cl JAOYKRSASYNDGH-BYPYZUCNSA-N 0.000 title claims abstract description 24
- 238000007036 catalytic synthesis reaction Methods 0.000 title claims description 6
- 239000013078 crystal Substances 0.000 claims abstract description 29
- 239000007810 chemical reaction solvent Substances 0.000 claims abstract description 24
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 18
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 claims abstract description 15
- 239000005515 coenzyme Substances 0.000 claims abstract description 15
- VJBFZHHRVCPAPZ-UHFFFAOYSA-N 1-(2,6-dichloro-3-fluorophenyl)ethanone Chemical compound CC(=O)C1=C(Cl)C=CC(F)=C1Cl VJBFZHHRVCPAPZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011575 calcium Substances 0.000 claims abstract description 13
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 13
- 230000003197 catalytic effect Effects 0.000 claims abstract description 8
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 7
- 239000000758 substrate Substances 0.000 claims abstract description 3
- 230000002195 synergetic effect Effects 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 47
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 31
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 30
- 238000005406 washing Methods 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000000047 product Substances 0.000 claims description 22
- 238000001035 drying Methods 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 20
- 239000012044 organic layer Substances 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 17
- 102000005751 Alcohol Oxidoreductases Human genes 0.000 claims description 16
- 108010031132 Alcohol Oxidoreductases Proteins 0.000 claims description 16
- 150000001299 aldehydes Chemical class 0.000 claims description 16
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 15
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 15
- 239000001506 calcium phosphate Substances 0.000 claims description 14
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 14
- 235000011010 calcium phosphates Nutrition 0.000 claims description 14
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000010410 layer Substances 0.000 claims description 10
- 239000008057 potassium phosphate buffer Substances 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 230000010355 oscillation Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 239000008055 phosphate buffer solution Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000004064 recycling Methods 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- 230000003287 optical effect Effects 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 238000004296 chiral HPLC Methods 0.000 description 8
- 238000005303 weighing Methods 0.000 description 8
- 239000002146 L01XE16 - Crizotinib Substances 0.000 description 7
- KTEIFNKAUNYNJU-GFCCVEGCSA-N crizotinib Chemical compound O([C@H](C)C=1C(=C(F)C=CC=1Cl)Cl)C(C(=NC=1)N)=CC=1C(=C1)C=NN1C1CCNCC1 KTEIFNKAUNYNJU-GFCCVEGCSA-N 0.000 description 7
- 229960005061 crizotinib Drugs 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- -1 2, 6-dichloro-3-fluoro-phenethyl Chemical group 0.000 description 4
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 4
- 101710168331 ALK tyrosine kinase receptor Proteins 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000003912 environmental pollution Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000003513 alkali Substances 0.000 description 2
- 238000004134 energy conservation Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- JAOYKRSASYNDGH-SCSAIBSYSA-N (1r)-1-(2,6-dichloro-3-fluorophenyl)ethanol Chemical compound C[C@@H](O)C1=C(Cl)C=CC(F)=C1Cl JAOYKRSASYNDGH-SCSAIBSYSA-N 0.000 description 1
- 101150023956 ALK gene Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 101100091501 Mus musculus Ros1 gene Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011337 individualized treatment Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003203 stereoselective catalyst Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 description 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/18—Multi-enzyme systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01002—Alcohol dehydrogenase (NADP+) (1.1.1.2), i.e. aldehyde reductase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711434891.1A CN108285908B (zh) | 2017-12-26 | 2017-12-26 | 一种固定化双酶催化合成(s)-1-(2,6-二氯-3-氟-苯基)乙醇的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711434891.1A CN108285908B (zh) | 2017-12-26 | 2017-12-26 | 一种固定化双酶催化合成(s)-1-(2,6-二氯-3-氟-苯基)乙醇的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108285908A CN108285908A (zh) | 2018-07-17 |
CN108285908B true CN108285908B (zh) | 2021-02-09 |
Family
ID=62832434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711434891.1A Active CN108285908B (zh) | 2017-12-26 | 2017-12-26 | 一种固定化双酶催化合成(s)-1-(2,6-二氯-3-氟-苯基)乙醇的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108285908B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110156564A (zh) * | 2019-05-17 | 2019-08-23 | 南京趣酶生物科技有限公司 | 一种s-手性醇中间体的提取方法 |
CN111474262B (zh) * | 2020-04-26 | 2023-03-28 | 中山奕安泰医药科技有限公司 | 克里唑替尼中间体的检测方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102925498A (zh) * | 2012-11-17 | 2013-02-13 | 苏州卡耐博生物技术有限公司 | 一种(r)1-(2,6-二氯-3-氟-苯基)乙醇的制备方法 |
CN104988132A (zh) * | 2015-06-19 | 2015-10-21 | 杭州师范大学 | 一种醛酮还原酶和葡萄糖脱氢酶的微波辅助共固定化方法 |
CN104988133A (zh) * | 2015-06-19 | 2015-10-21 | 杭州师范大学 | 一种醛酮还原酶和葡萄糖脱氢酶的包埋共固定化方法 |
CN105754983A (zh) * | 2016-05-19 | 2016-07-13 | 河北周酶生物科技有限公司 | 一种用于制备依折麦布中间体的固定化酶及其制备方法 |
CN106047950A (zh) * | 2016-06-30 | 2016-10-26 | 尚科生物医药(上海)有限公司 | 一种(s)‑1‑(2,6‑二氯‑3‑氟苯基)乙醇的生物制备方法 |
CN107418980A (zh) * | 2017-06-16 | 2017-12-01 | 义乌市欣邦生物科技有限公司 | 一种r‑3,5‑双三氟甲基苯乙醇的清洁生产方法 |
-
2017
- 2017-12-26 CN CN201711434891.1A patent/CN108285908B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102925498A (zh) * | 2012-11-17 | 2013-02-13 | 苏州卡耐博生物技术有限公司 | 一种(r)1-(2,6-二氯-3-氟-苯基)乙醇的制备方法 |
CN104988132A (zh) * | 2015-06-19 | 2015-10-21 | 杭州师范大学 | 一种醛酮还原酶和葡萄糖脱氢酶的微波辅助共固定化方法 |
CN104988133A (zh) * | 2015-06-19 | 2015-10-21 | 杭州师范大学 | 一种醛酮还原酶和葡萄糖脱氢酶的包埋共固定化方法 |
CN105754983A (zh) * | 2016-05-19 | 2016-07-13 | 河北周酶生物科技有限公司 | 一种用于制备依折麦布中间体的固定化酶及其制备方法 |
CN106047950A (zh) * | 2016-06-30 | 2016-10-26 | 尚科生物医药(上海)有限公司 | 一种(s)‑1‑(2,6‑二氯‑3‑氟苯基)乙醇的生物制备方法 |
CN107418980A (zh) * | 2017-06-16 | 2017-12-01 | 义乌市欣邦生物科技有限公司 | 一种r‑3,5‑双三氟甲基苯乙醇的清洁生产方法 |
Non-Patent Citations (2)
Title |
---|
A new lipase–inorganic hybrid nanoflower with enhanced enzyme activity;Ke, C.等;《RSC Advances》;20161231;第23卷(第6期);摘要,第19413页右栏第三段到第19414页第一段 * |
A new nanobiocatalytic system based on allosteric effect with dramatically enhanced enzymatic performance;Wang,L.B.等;《J Am Chem Soc》;20130130;第135卷(第4期);第1272-1275页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108285908A (zh) | 2018-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108285908B (zh) | 一种固定化双酶催化合成(s)-1-(2,6-二氯-3-氟-苯基)乙醇的方法 | |
CN103898177B (zh) | 制备高手性纯(r)-3-哌啶醇及其衍生物的方法 | |
CN102206686B (zh) | 生物催化不对称还原制备(r)-邻氯扁桃酸甲酯的方法 | |
CN102925418B (zh) | 一种α-熊果苷生产过程中蔗糖磷酸化酶的回收方法 | |
Xie et al. | Adzuki bean: a new resource of biocatalyst for asymmetric reduction of aromatic ketones with high stereoselectivity and substrate tolerance | |
CN104894171A (zh) | 以木薯淀粉为原料发酵生产(r,r)-2,3-丁二醇的方法 | |
Zhang et al. | Upscale production of (R)-mandelic acid with a stereospecific nitrilase in an aqueous system | |
CN103898178B (zh) | 酶法制备高手性纯(s)-3-哌啶醇及其衍生物的方法 | |
CN107586793A (zh) | 制备具有多个手性中心的醇化合物的方法 | |
CN101709322B (zh) | 生物催化白桦脂醇合成白桦脂酸的方法 | |
CN108753851B (zh) | 羰基还原酶生物催化生产手性1,2-二醇类化合物 | |
CN105925558B (zh) | 一种用于制备他汀类药物的复合固定化酶及其制备方法 | |
Wu et al. | Highly efficient dynamic kinetic resolution of secondary aromatic alcohols at low temperature using a low-cost sulfonated sepiolite as racemization catalyst | |
JP2010532992A (ja) | 3,4−エポキシ酪酸エチルの微生物速度論的分割 | |
CN1333068C (zh) | 生物催化制备(s)-4-氯-3-羟基丁酸酯的菌种和方法 | |
CN109402190A (zh) | 一种糠醇的制备方法 | |
CN103484505B (zh) | 利用链格孢属微生物胞内酶转化葡萄糖生成白藜芦醇的方法 | |
CN104372039A (zh) | 双酶法制备瑞舒伐他汀侧链中间体的方法 | |
CN102409068A (zh) | 一种(3aS,6aR)-生物素手性内酯的制备方法 | |
CN103305584B (zh) | 一种酶催化拆分光学纯2-辛醇的方法 | |
CN104313074A (zh) | 一种青霉催化生产吡啶基乙醇方法 | |
CN104450801B (zh) | 一种双酶法不对称制备(r)‑2‑氯‑1‑(3‑氯苯基)乙醇的应用 | |
CN104372041B (zh) | 一种全细胞催化制备(s)‑4‑氯‑3‑羟基丁酸乙酯的方法 | |
CN104342464A (zh) | 一种黄蓝状菌催化生产手性苯基甲醇方法 | |
CN104263774A (zh) | 一种酿酒酵母催化生产手性亚环己基烯醇的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240319 Address after: Room 660, West Tower, 6th Floor, Building 2, No. 128, 18th Street (East), Baiyang Street, Qiantang District, Hangzhou City, Zhejiang Province, 310000 Patentee after: Zhejiang Jiushi Biotechnology Co.,Ltd. Country or region after: Zhong Guo Address before: No.16, Xuelin street, Xiasha Higher Education Park, Jianggan District, Hangzhou City, Zhejiang Province, 310036 Patentee before: Hangzhou Normal University Country or region before: Zhong Guo |